Trilobatin attenuates the LPS-mediated inflammatory response by suppressing the NF-κB signaling pathway. [electronic resource]
Producer: 20150616Description: 609-615 p. digitalISSN:- 1873-7072
- Animals
- Anti-Inflammatory Agents -- pharmacology
- Cell Line, Tumor
- Cell Survival -- drug effects
- Dose-Response Relationship, Drug
- Fagaceae -- chemistry
- Female
- Flavonoids -- pharmacology
- I-kappa B Proteins -- genetics
- Interleukin-1beta -- metabolism
- Interleukin-6 -- metabolism
- Lipopolysaccharides -- adverse effects
- Mice
- Mice, Inbred BALB C
- NF-KappaB Inhibitor alpha
- NF-kappa B -- genetics
- Phosphorylation -- drug effects
- Polyphenols -- pharmacology
- RNA, Messenger -- genetics
- Signal Transduction
- Transcription Factor RelA -- genetics
- Tumor Necrosis Factor-alpha -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.